Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.2525
-0.0195 (-7.17%)
At close: Aug 28, 2026, 4:00 PM EDT
0.2575
+0.0050 (1.98%)
After-hours: Aug 28, 2026, 7:52 PM EDT
Mereo BioPharma Group Stock Forecast
MREO's stock price has decreased by -85.65% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 8 analysts polled by S&P Global, Mereo BioPharma Group stock has a consensus rating of "Buy" and an average price target of $2.01. The average 1-year stock price forecast is 696.04% higher than the current stock price, while the lowest is $1.01 (+300.00%) and the highest is $3.03 (+1,100.00%).
Price Target: $2.01 (+696.04%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Mereo BioPharma Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Sell Downgrades n/a | Sell | Downgrades | n/a | n/a | Aug 18, 2026 |
| LifeSci Capital | LifeSci Capital | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 15, 2026 |
| Needham | Needham | Buy Maintains $3 | Buy | Maintains | $3 | +1,088.12% | Aug 11, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $3 | Buy | Maintains | $3 | +1,088.12% | May 12, 2026 |
| BTIG | BTIG | Buy Maintains $1 | Buy | Maintains | $1 | +296.04% | Mar 20, 2026 |
Financial Forecast
Revenue This Year
n/a
from 500.00K
Decreased by -100.00%
Revenue Next Year
19.20M
EPS This Year
n/a
EPS Next Year
n/a